Efficacy News and Research

RSS

Comprehensive review outlines engineering-driven therapeutic pathways for spinal cord injuries

A comprehensive review published in Engineering outlines multi-disciplinary engineering approaches addressing spinal cord injury (SCI), a debilitating central nervous system disorder triggering permanent sensory, motor, and autonomic dysfunction, and imposing heavy burdens on individuals and societies worldwide.

21 Aug 2026

Digital program reduces anxiety and depression in adults with chronic medical conditions

A digital program combining guided movement, breathing and meditation exercises, and coping-skills training reduced anxiety and depression symptoms in adults with chronic medical conditions, according to a new study published August 20th in the open access journal PLOS Medicine by Puneeta Tandon of the University of Alberta, Canada, and colleagues.

20 Aug 2026

Psilocybin may make the brain more organized than scientists expected

In 62 adults, researchers combined fMRI, EEG and machine learning to examine how psilocybin reshapes brain activity during rest, meditation, music and movie viewing. They found that context-sensitive neural organization tracked the intensity and quality of psychedelic experiences and was associated with next-day mindset change.

20 Aug 2026

What happens to your diet when you get better at cooking?

Cooking-skills interventions were associated with healthier dietary behaviors in healthy adults, including greater fruit and vegetable intake, improved diet quality, and greater cooking confidence. However, the certainty of evidence was low to very low, and too little evidence was available to determine whether cooking skills affect nutritional status.

20 Aug 2026

Federal and industry sponsors play complementary roles in cancer clinical trials

A comparative study of the cancer clinical trial portfolios supported by federal funding versus industry funding reveals they have distinct, interdependent roles in cancer research.

20 Aug 2026

Semaglutide trial targets people with liver disease, obesity and alcohol addiction

A new study -- co-led by the University of Plymouth, University Hospitals Plymouth NHS Trust, and the NIHR Biomedical Research Centre: Nottingham -- is being launched into a treatment for people impacted by liver disease, obesity and alcohol addiction.

19 Aug 2026

OIST startup aims to develop effective pain relief without severe side effects

For severe and chronic pain management, opioids are often the only option. This class of drugs comes with well-documented risks, including addiction, respiratory problems and overdose.

18 Aug 2026

Engineered red blood cell vesicles improve gene therapy delivery

Red blood cells serve as the foundation for nanocarriers that show promise in a new study as effective and efficient vehicles for gene therapy, tumor targeting and other medical treatments.

17 Aug 2026

Polydatin reduces ulcerative colitis by regulating intestinal immune cells

Ulcerative colitis (UC) is a chronic inflammatory bowel disease in which recurrent intestinal inflammation can be difficult to control over the long term.

17 Aug 2026

Digital program proves effective for treating childhood anxiety symptoms

The follow-up of a randomized controlled trial shows that the internet-based Master Your Worries intervention program for treating children's anxiety has a long-term effect on the participants.

17 Aug 2026

Self-guided online compassion therapy may improve quality of life in chronic illness

A fully self-guided, internet-delivered attachment-based compassion therapy improved overall quality of life and reduced preoccupied attachment compared with a waiting-list control in adults with chronic medical conditions. The findings are preliminary, with high attrition, no active control, and most secondary psychological outcomes showing no significant between-group differences.

16 Aug 2026

Placental biology breakthrough could make biologic medicines safer during pregnancy

Biologic medicines have transformed the treatment of cancer, autoimmune diseases, migraine, inflammatory disorders and many other diseases.

14 Aug 2026

Würzburg researchers discover alternative approach to preventing thrombosis

Glycoprotein VI, or GPVI for short, is a surface receptor found exclusively on platelets and their precursor cells, megakaryocytes in the bone marrow.

14 Aug 2026

In a famous Blue Zone, daily movement was tied to fewer memory complaints

Older adults in Sardinian Blue Zone communities who took more daily steps, spent less time sedentary, perceived their physical health more positively, and had greater confidence in their memory reported fewer memory complaints. Sleep efficiency was not significantly associated with memory complaints, and the cross-sectional study cannot establish cause and effect.

13 Aug 2026

Trauma-informed guideline can reduce CPS reporting for infants with prenatal opioid exposure

A new study conducted at Boston Medical Center (BMC), New England's largest essential hospital, found that a trauma-informed clinical guideline can help reduce reflexive Child Protective Services (CPS) reporting without compromising child safety.

13 Aug 2026

Insilico Medicine nominates powerful oral drug candidate for the management of heart risks

Insilico Medicine, a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, today announced the nomination of ISM0900, a potent, AI-driven, highly selective, orally available small molecule inhibitor of lipoprotein(a), or Lp(a), as a preclinical candidate (PCC) for the management of cardiovascular risks.

12 Aug 2026

CN Bio awarded Innovate UK grant to reduce animal use in pharmacokinetic studies

CN Bio, a leading provider of Organ-on-a-chip (OOC) Systems and solutions that accelerate drug discovery and development workflows, today announced it has been awarded £180 k grant funding from Innovate UK.

From CN Bio 12 Aug 2026

Contaminated soil can bring hazardous lead dust into homes

Lead contamination in soil tracked inside homes can cause dangerous indoor lead dust levels even in residences with no interior lead-based paint, according to researchers with the Rutgers Environmental, Occupational and Health Sciences Institute in collaboration with community scientists from the East Trenton Collaborative.

11 Aug 2026

Genetic tool turns soft cancer cells into immune targets

Researchers at the USC Viterbi School of Engineering and Keck School of Medicine of USC have engineered a remarkable genetic tool that addresses one of the most persistent obstacles in cancer immunotherapy: the physical softness of tumors.

11 Aug 2026

New study identifies key pathway for delivering antisense cancer drugs

Antisense oligonucleotides (ASOs) have been proposed as a therapeutic approach to shut down the production of faulty proteins in a wide variety of diseases, including cancer.

11 Aug 2026

Previous
1
...
3
4
5
6
7
8
9
...
1332
Next

Efficacy News and Research

Comprehensive review outlines engineering-driven therapeutic pathways for spinal cord injuries

Digital program reduces anxiety and depression in adults with chronic medical conditions

Psilocybin may make the brain more organized than scientists expected

What happens to your diet when you get better at cooking?

Federal and industry sponsors play complementary roles in cancer clinical trials

Semaglutide trial targets people with liver disease, obesity and alcohol addiction

OIST startup aims to develop effective pain relief without severe side effects

Engineered red blood cell vesicles improve gene therapy delivery

Polydatin reduces ulcerative colitis by regulating intestinal immune cells

Digital program proves effective for treating childhood anxiety symptoms

Self-guided online compassion therapy may improve quality of life in chronic illness

Placental biology breakthrough could make biologic medicines safer during pregnancy

Würzburg researchers discover alternative approach to preventing thrombosis

In a famous Blue Zone, daily movement was tied to fewer memory complaints

Trauma-informed guideline can reduce CPS reporting for infants with prenatal opioid exposure

Insilico Medicine nominates powerful oral drug candidate for the management of heart risks

CN Bio awarded Innovate UK grant to reduce animal use in pharmacokinetic studies

Contaminated soil can bring hazardous lead dust into homes

Genetic tool turns soft cancer cells into immune targets

New study identifies key pathway for delivering antisense cancer drugs

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News